Cutaneous complications among i.v. buprenorphine users

Journal of Dermatology

Volumn 36, Issue 1, 2009, Pages 22-29

  Ho, Roger C M ^a,b   Ho, Emily C L ^b   Mak, Anselm ^c  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

Buprenorphine; Cutaneous complications; i.v. drug abuse

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BUPRENORPHINE; C REACTIVE PROTEIN; CLOXACILLIN; GENTAMICIN; PENICILLIN G;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; BODY TEMPERATURE; BREATHING RATE; CELLULITIS; CLINICAL ARTICLE; ENTEROBACTERIACEAE INFECTION; FEMALE; HEART RATE; HEMATOMA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFECTION; LENGTH OF STAY; LEUKOCYTE COUNT; LYMPHADENOPATHY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOTIC ANEURYSM; NECROTIZING FASCIITIS; NEUTROPHIL COUNT; OSTEOMYELITIS; PRESCRIPTION; PROTEIN BLOOD LEVEL; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; SEPTIC SHOCK; SINGAPORE; SKIN ABSCESS; SKIN CULTURE; SKIN DISEASE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MILLERI; STREPTOCOCCUS VIRIDANS INFECTION; SURGICAL DRAINAGE; THROMBOPHLEBITIS; UNIVERSITY HOSPITAL;

ABSCESS; ADULT; BUPRENORPHINE; CELLULITIS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; SINGAPORE; SKIN DISEASES; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCAL INFECTIONS;

EID: 59549098214     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2008.00581.x     Document Type: Article

References (20)

1. Auriacombe M, Fatseas M, Dubernet J, Daulouede JP, Tignol J. French field experience with buprenorphine. Am J Addict 2004 13 : S17 S28.
2. Nielsen S, Diete P, Lee N, Dunlop A, Taylor D. Concurrent buprenorphine and benzodiazepine use and self reported opioid toxicity in opioid substitution treatment. Addiction 2007 102 : 616 622.
3. Kakko J, Gronbladh L, Svanborg KD et al. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am J Psychiatry 2007 164 : 797 803.
4. Luty J, O'Gara C, Sessay M. Is methadone too dangerous for opiate addiction? BMJ 2005 331 : 1352 1353.
5. World Health Organization. WHO Essential Medicines Library. [Cited 1 Jun 2007.] Available from URL: http://mednet3.who.int/EMlib/
6. Guichard A, Lert F, Calderon C et al. Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France. Addiction 2003 98 : 1585 1597.
7. Jenkinson RA, Clark NC, Fry CL, Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? Addiction 2005 100 : 197 205.
8. Nielsen S, Dietze P, Dunlop A, Muhleisen P, Lee N, Taylor D. Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified. Drug Alcohol Rev 2007 26 : 143 151.
9. Giudice PD. Cutaneous complications of intravenous drug abuse. Br J Dermatol 2004 150 : 1 10.
10. Rasokat H. Skin changes in drug-dependent patients. Z Hautkr 1990 65 : 351 354, 357.
11. Buprenorphine replacement therapy: a confirmed benefit. Prescrire Int 2006 15 : 64 70.
12. Chawarski MC, Mazlan M, Schottenfeld RS. Heroin dependence and HIV infection in Malaysia. Drug Alcohol Depend 2006 82 Suppl 1 : S39 42.
13. Martinez EA, Hartsfield SM, Melendez LD, Matthews NS, Slater MR. Cardiovascular effects of buprenorphine in anesthetized dogs. Am J Vet Res 1997 58 : 1280 1284.
14. Beauchamp NJ Jr., Scott WW Jr., Gottleb LM, Fishman EK. CT evaluation of soft tissue and muscle infection and inflammation: a systematic compartmental approach. Skeletal Radiol 1995 24 : 317 324.
15. Beltran J. MR imaging of soft tissue infection. Magn Reason Imaging Clin N Am 1995 3 : 743 751.
16. Hook III. EW, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 1986 146 : 295 7.
17. Veien NK. The clinician's choice of antibiotics in the treatment of bacterial skin infection. Br J Dermatol 1998 139 : 30 36.
18. Guay DR. Treatment of bacterial skin and skin structure infections. Expert Opin Pharmacother 2003 4 : 1259 75.
19. Orangio GR, Pitlick SD, Della Latta P et al. Soft tissue infections in parenteral drug abusers. Ann Surg 1984 199 : 97 100.
20. Baddour LM. Recent considerations in recurrent cellulitis. Curr Infect Dis Rep 2001 3 : 461 465.